Investigator- and Patient-Rated Local Tolerability in Phase 3 Trials of Topical Roflumilast in Patients With Psoriasis, Seborrheic Dermatitis, and Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s251, 2023. DOI: 10.25251/skin.7.supp.251. Disponível em: https://skin.dermsquared.com/skin/article/view/2398. Acesso em: 10 apr. 2025.